Progressing Spatial Biology & Digital Pathology into the Clinic to Achieve Unique Insights & Meaningful Clinical Outcomes

  • Validating novel technologies and demonstrating their value as tools for clinical progression
  • Navigating the regulatory landscape of bringing spatial omics & digital pathology into clinical studies
  • Clinical data to highlight the unique benefit of employing spatial biology and digital pathology for patient selection, biomarker validation and toxicity testing